Tag Archives: mutual funds

Third Avenue Focused Credit’s Investor Freeze Re-Affirms Advantage Of Closed End Funds

Third Avenue Focused Credit shutting the gate on redemptions. A reminder that traditional open-end mutual funds can suffer “runs on the bank” if they hold illiquid assets during nervous market periods. Reminds us that closed end funds are the safer vehicle to hold high yield and other more illiquid asset classes. Third Avenue Focused Credit Fund ( TFCIX , TFCVX ) just dropped the bombshell that they are freezing the fund and barring investor withdrawals as it seeks an orderly liquidation. TFCIX, as a sort of “vulture fund,” operates at the lowest end of the high-yield bond spectrum, specializing in bankruptcies, turnarounds and other bottom-of-the-barrel opportunities. I had personally been quite enamored of the fund when it was launched in 2009 as a vehicle to take advantage of post-crash credit market bargains. In that sense I saw it as a vehicle for retail investors to get in on the opportunities typically only available to hedge fund and other institutional investors. The fund’s “Achilles Heel” turned out to be its status as a traditional “open end” mutual fund, where investors could liquidate their positions on a daily basis. In fact, in recent years it was the only open-end mutual fund I had continued to hold, feeling personally more comfortable with closed end funds where, if other investors want to bail out, they have to sell their fund on the open market, and cannot demand the funds’ portfolio managers cash them out at NAV by selling fund assets. That is a much safer vehicle for holding potentially illiquid assets, as high yielding assets like junk bonds, MLPs, BDCs, etc. have turned out to be recently. I started selling out my TFCIX a few months ago (as I explained in an article in early November), not because I was worried about the fund freezing its assets (I wasn’t that smart), but rather because I saw a unique opportunity, since it was an open-end fund offering cash back at full NAV value, to take advantage of that and put the funds back into the market via closed end funds at 10% discounts (or more.) So that’s what I did, completing my exit later in the month. By way of post mortem, I ran the numbers on my total investment in TFCIX over the past six years. I collected back 34% of the total investment in dividends over the holding period, about 8% per annum, accounting for the timing of the investment (i.e. it wasn’t all outstanding the entire period). Then I gave back about 25% of the total investment in capital loss. That means I only made about 9% in total on my money, spread over 6 years. An opportunity cost, for sure, and a waste of earning power, since if invested better it would have been earning 6-7%. But – fortunately – not a disaster. To me this reinforces: · The attractiveness of closed end funds as the vehicle of choice for holding high-yielding illiquid assets, since you have the option of sitting out periods of market volatility while clipping your coupons and waiting for the storm to pass; and · The advantages of holding high yielding assets (equity and fixed income) in general, as a hedge against market losses, since the cash flow acts as a buffer over time to offset market depreciation.

4 Top-Ranked Healthcare Mutual Funds To Boost Your Return

When markets are plying through choppy waters, investors often rely on the healthcare sector to safeguard their investments. This is because the demand for healthcare services does not vary so much with market conditions, making them a safe haven in difficult times. Many pharma companies also generate regular dividends, which go a long way in softening the blow dealt by plummeting share prices. Mutual funds are the perfect choice for investors looking to enter this sector, since they possess the advantages of wide diversification and analytical insight. Below, we share with you 4 top-rated healthcare mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy), and we expect each fund to outperform its peers in the future. To view the Zacks Rank and past performance of all healthcare mutual funds, click here . Fidelity Select Pharmaceuticals Portfolio No Load (MUTF: FPHAX ) seeks growth of capital. The fund invests a lion’s share of its assets in securities of companies involved in operations, including manufacturing, distribution and development of pharmaceuticals and drugs. It generally focuses on acquiring common stocks of companies located throughout the globe. Factors including economic condition and financial strength are taken into consideration before investing in securities of a company. The Fidelity Select Pharmaceuticals Portfolio No Load is a non-diversified fund and has a three-year annualized return of 22.9%. Asher Anolic has been the fund manager of FPHAX since 2013. T. Rowe Price Health Sciences Fund No Load (MUTF: PRHSX ) invests a major portion of its assets in common stocks of companies whose primary operations are related to health sciences. It focuses on investing in large and mid-cap firms. The T. Rowe Price Health Sciences Fund No Load has a three-year annualized return of 30%. As of September 2015, PRHSX held 160 issues, with 4.97% of its assets invested in Allergan plc (NYSE: AGN ). Vanguard Health Care Fund Investor (MUTF: VGHCX ) seeks long-term capital growth. The fund invests a large chunk of its assets in securities of companies primarily involved in operations related to the healthcare domain. VGHCX invests in healthcare companies, including pharmaceutical firms, medical supply companies and companies engaged in operations related to medical and biochemical. It may invest a maximum of half of its assets in companies located in foreign lands. The Vanguard Health Care Fund Investor has a three-year annualized return of 26.8%. VGHCX has an expense ratio of 0.34%, as compared to the category average of 1.33%. Fidelity Select Medical Delivery Portfolio No Load (MUTF: FSHCX ) invests the majority of its assets in companies that either own or are involved in operating hospital and nursing homes, and are related to the healthcare services sector. It focuses on acquiring common stocks of issuers all over the world. The Fidelity Select Medical Delivery Portfolio No Load fund has a three-year annualized return of 20.8%. As of October 2015, the fund held 47 issues, with 19.06% of its assets invested in UnitedHealth Group Inc (NYSE: UNH ). Original Post

5 Strong Buy Vanguard Mutual Funds

Vanguard is one of the world’s largest asset management corporations that manage around $3 trillion in assets. It offers nearly 160 domestic funds and 120 funds for foreign markets (as of Dec. 31, 2014). It offers asset management and financial planning services to clients across the world. Unlike other mutual fund companies, Vanguard is owned by the funds themselves, which helps its management focus better on shareholder interests. Among other advantages, it claims to offer low-cost, no-load funds. Vanguard was founded by John C. Bogle in 1975. Below, we share with you 5 top-rated Vanguard mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy), and we expect the fund to outperform its peers in the future. Vanguard Health Care Fund Inv (MUTF: VGHCX ) invests a major portion of its assets in securities of companies primarily involved in operations related to the healthcare domain. VGHCX invests in healthcare companies including pharmaceutical firms, medical supply companies and companies engaged in operations related to medical and biochemical. VGHCX may invest a maximum of half of its assets in companies located in foreign lands. The Vanguard Health Care Investor Fund has returned 10.3% in the year-to-date frame. Jean M. Hynes is the fund manager of VGHCX since 2008. Vanguard Morgan Growth Fund Investor (MUTF: VMRGX ) seeks capital appreciation over the long run. VMRGX uses multiple advisors to invest in domestic companies that are believed to provide above-average revenues and earnings growth. VMRGX invests in securities of companies having large and medium sized market capitalizations. The Vanguard Morgan Growth Investor Fund has returned 7.1% in the year-to-date frame. VMRGX has an expense ratio of 0.40% as compared to the category average of 1.19%. Vanguard Growth and Income Fund Inv (MUTF: VQNPX ) invests in a diversified group of stocks chosen with the help of quantitative analysis. VQNPX seeks stocks that are believed to provide dividend income and have impressive growth prospect and that, as a group, appear likely to provide higher returns than the Standard & Poor’s 500 Index while having similar risk characteristics. VQNPX invests a minimum of 65% of its assets in companies included in the index. The Vanguard Growth and Income Investor Fund has returned 2.2% in the year-to-date frame. As of September 2015, VQNPX held 786 issues with 3.33% of its assets invested in Apple, Inc. (NASDAQ: AAPL ). Vanguard New York Long-Term Tax-Exempt Fund Inv (MUTF: VNYTX ) seeks tax-exempted current income. VNYTX generally invests in municipal debt securities of New York state, local governments and other affiliates. VNYTX invests a lion’s share of its assets in securities that are expected to provide return free from federal and New York state taxes. VNYTX generally maintains a dollar-weighted average maturity between 10 and 25 years. The Vanguard New York Long-Term Tax-Exempt Investor is a non-diversified fund and has returned 3.2% in the year-to-date frame. VNYTX has an expense ratio of 0.20% as compared to the category average of 0.87%. Vanguard High-Yield Tax-Exempt Fund Inv (MUTF: VWAHX ) invests a large chunk of its assets in municipal securities that are rated investment grade by a nationally recognized statistical rating organization (NRSRO). However, a maximum of 20% of VWAHX’s assets may get invested in securities that are rated below investment grade. The Vanguard High-Yield Tax-Exempt Fund has returned 3.2% in the year-to-date frame. Mathew M. Kiselak is the fund manager of VWAHX since 2010. Original post